This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beijing Hanmi Pharmaceutical Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Baoyu Xue and His Pharmaceutical Invention.
Introduction
Baoyu Xue is an inventor based in Beijing, China, associated with Beijing Hanmi Pharmaceutical Co., Ltd. His patent work concerns pharmaceutical research, particularly compounds that inhibit IRAK4 kinase activity.
Latest Patents
The supplied information lists 1 patent for Baoyu Xue: “IRAK4 inhibitor and use thereof.” The invention describes a compound that inhibits IRAK4 kinase activity, along with a pharmaceutical composition and potential uses in preparing medicines. It also covers methods for inhibiting the kinase and for treating or preventing IRAK4-mediated diseases or conditions in mammals, particularly humans. The compound is identified by structural formula I.
Career Highlights
Xue’s listed patent reflects work on a targeted approach to developing medicines for conditions mediated by IRAK4 kinase. The supplied information identifies Beijing Hanmi Pharmaceutical Co., Ltd. as his company.
Collaborations
The listed coworkers associated with Xue are Runa Zheng and Maengsup Kim. Their names appear alongside the patent information provided.
Conclusion
Baoyu Xue’s recorded patent activity centers on an IRAK4-inhibiting compound and its potential pharmaceutical applications, connecting his work in Beijing with research at Beijing Hanmi Pharmaceutical Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile